Construction of lung cancer serum markers based on ReliefF feature selection

References

• Adams E, Sepich-Poore GD, Miller-Montgomery S, Knight R. 2022. Using all our genomes: blood-based liquid biopsies for the early detection of cancer. View (Beijing, China). 3(1):20200118. doi:10.1002/VIW.20200118.
   PubMedGoogle Scholar
• Asakura K, Kadota T, Matsuzaki J, Yoshida Y, Yamamoto Y, Nakagawa K, Takizawa S, Aoki Y, Nakamura E, Miura J, et al. 2020. A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy. Commun Biol. 3(1):134. doi:10.1038/s42003-020-0863-y.
   PubMed Web of Science ®Google Scholar
• Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et al. 2012. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 307(22):2418–2429. doi:10.1001/jama.2012.5521.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. 2006. MicroRNA signatures in human cancers. Nat Rev Cancer. 6(11):857–866. doi:10.1038/nrc1997.
   PubMed Web of Science ®Google Scholar
• Carpenter KA, Huang X. 2018. Machine learning-based virtual screening and its applications to Alzheimer’s drug discovery: a review. Curr Pharm Des. 24(28):3347–3358. doi:10.2174/1381612824666180607124038.
   PubMed Web of Science ®Google Scholar
• Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallieres E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, et al. 2017. The IASLC lung cancer staging project: external Validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 12(7):1109–1121. doi:10.1016/j.jtho.2017.04.011.
   PubMed Web of Science ®Google Scholar
• Du G, Yu X, Chen Y, Cai W. 2021. MiR-1-3p suppresses colorectal cancer cell proliferation and metastasis by inhibiting YWHAZ-mediated epithelial-mesenchymal transition. Front Oncol. 11:634596. doi:10.3389/fonc.2021.634596.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. 2010. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17(6):1471–1474. doi:10.1245/s10434-010-0985-4.
   PubMed Web of Science ®Google Scholar
• Feng PM, Ding H, Chen W, Lin H. 2013. Naive Bayes classifier with feature selection to identify phage virion proteins. Comput Math Methods Med. 2013:530696. doi:10.1155/2013/530696.
   PubMed Web of Science ®Google Scholar
• Ferrell B, Koczywas M, Grannis F, Harrington A. 2011. Palliative care in lung cancer. Surg Clin North Am. 91(2):403–417, ix. doi:10.1016/j.suc.2010.12.003.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Shoorei H, Taheri M. 2020. miRNA profile in ovarian cancer. Exp Mol Pathol. 113:104381. doi:10.1016/j.yexmp.2020.104381.
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. 2010. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 251(3):499–505. doi:10.1097/SLA.0b013e3181cc939f.
   PubMed Web of Science ®Google Scholar
• Hoy H, Lynch T, Beck M. 2019. Surgical treatment of lung cancer. Crit Care Nurs Clin North Am. 31(3):303–313. doi:10.1016/j.cnc.2019.05.002.
   PubMed Web of Science ®Google Scholar
• Huang S, Cai N, Pacheco PP, Narrandes S, Wang Y, Xu W. 2018. Applications of support vector machine (SVM) learning in cancer genomics. Cancer Genomics Proteomics. 15(1):41–51.
   PubMed Web of Science ®Google Scholar
• Huang C, Sun Y, Ma S, Vadamootoo AS, Wang L, Jin C. 2019. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma. Pathol Res Pract. 215(6):152411. doi:10.1016/j.prp.2019.04.003.
   PubMed Web of Science ®Google Scholar
• Lan H, Lu H, Wang X, Jin H. 2015. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int. 2015:125094. doi:10.1155/2015/125094.
   PubMed Web of Science ®Google Scholar
• Le NQK, Do DT, Nguyen TT, Le QA. 2021. A sequence-based prediction of Kruppel-like factors proteins using XGBoost and optimized features. Gene. 787:145643. doi:10.1016/j.gene.2021.145643.
   PubMed Web of Science ®Google Scholar
• Li Y, Hong HG, Li Y. 2019. Multiclass linear discriminant analysis with ultrahigh-dimensional features. Biometrics. 75(4):1086–1097. doi:10.1111/biom.13065.
   PubMed Web of Science ®Google Scholar
• Liu K, Chen Q, Huang GH. 2023. An efficient feature selection algorithm for gene families using NMF and relieff. Genes. 14(2):421. doi:10.3390/genes14020421.
   PubMed Web of Science ®Google Scholar
• Liu S, Hu Y, Wu S, He Y, Deng L. 2020. MicroRNA-663 regulates melanoma progression by inhibiting FHL3. Technol Cancer Res Treat. 19:1533033820957000. doi:10.1177/1533033820957000.
   Web of Science ®Google Scholar
• Mishra S. 2017. Handling imbalanced data: SMOTE vs. random undersampling. Int Res J Eng Technol. 04(08):317–320.
   Google Scholar
• Nakamura K, Hiyake N, Hamada T, Yokoyama S, Mori K, Yamashiro K, Beppu M, Sagara Y, Sagara Y, Sugiura T. 2021. Circulating microRNA panel as a potential novel biomarker for oral squamous cell carcinoma diagnosis. Cancers (Basel). 13(3):449. doi:10.3390/cancers13030449.
   PubMed Web of Science ®Google Scholar
• Osmani L, Askin F, Gabrielson E, Li QK. 2018. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 52(Pt 1):103–109. doi:10.1016/j.semcancer.2017.11.019.
   PubMed Web of Science ®Google Scholar
• Pan Y, Gao H, Lin H, Liu Z, Tang L, Li S. 2018. Identification of bacteriophage virion proteins using multinomial naive Bayes with g-gap feature tree. Int J Mol Sci. 19(6):1779
   Web of Science ®Google Scholar
• Peng Y, Croce CM. 2016. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 1:15004. doi:10.1038/sigtrans.2015.4.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7):e47. doi:10.1093/nar/gkv007.
   PubMed Web of Science ®Google Scholar
• Robnik-Šikonja M, Kononenko I. 2003. Theoretical and empirical analysis of ReliefF and RReliefF. Machine Learn. 53(1/2):23–69. doi:10.1023/A:1025667309714.
   Web of Science ®Google Scholar
• Ros-Mazurczyk M, Jelonek K, Marczyk M, Binczyk F, Pietrowska M, Polanska J, Dziadziuszko R, Jassem J, Rzyman W, Widlak P. 2017. Serum lipid profile discriminates patients with early lung cancer from healthy controls. Lung Cancer. 112:69–74. doi:10.1016/j.lungcan.2017.07.036.
   PubMed Web of Science ®Google Scholar
• Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H. 2010. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 12(6):R90. doi:10.1186/bcr2766.
   PubMed Web of Science ®Google Scholar
• Saltybaeva N, Martini K, Frauenfelder T, Alkadhi H. 2016. Organ dose and attributable cancer risk in lung cancer screening with low-dose computed tomography. PLoS One. 11(5):e0155722. doi:10.1371/journal.pone.0155722.
   PubMed Web of Science ®Google Scholar
• Shin VY, Chu KM. 2014. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol. 20(30):10432–10439. doi:10.3748/wjg.v20.i30.10432.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Tailor TD, Choudhury KR, Tong BC, Christensen JD, Sosa JA, Rubin GD. 2019. Geographic access to CT for lung cancer screening: a census tract-level analysis of cigarette smoking in the United States and driving distance to a CT facility. J Am Coll Radiol. 16(1):15–23. doi:10.1016/j.jacr.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Tan JX, Dao FY, Lv H, Feng PM, Ding H. 2018. Identifying phage virion proteins by using two-step feature selection methods. Molecules. 23(8):2000. doi:10.3390/molecules23082000.
   PubMed Web of Science ®Google Scholar
• Vanhie A, O D, Peterse D, Beckers A, Cuellar A, Fassbender A, Meuleman C, Mestdagh P, D’Hooghe T. 2019. Plasma miRNAs as biomarkers for endometriosis. Hum Reprod. 34(9):1650–1660. doi:10.1093/humrep/dez116.
   PubMed Web of Science ®Google Scholar
• Vinod SK, Hau E. 2020. Radiotherapy treatment for lung cancer: current status and future directions. Respirology. 25 Suppl 2:61–71. doi:10.1111/resp.13870.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu H, Shen Y, Li W, Chen Y, Wang H. 2018. Low-dose computed tomography (LDCT) versus other cancer screenings in early diagnosis of lung cancer: A meta-analysis. Medicine (Baltimore). 97(27):e11233. doi:10.1097/MD.0000000000011233.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang M, Pan X, Zhao M, Huang L, Hu X, Wang X, Qiao L, Guo Q, Xu W, et al. 2022. Integrative serum metabolic fingerprints based multi-modal platforms for lung adenocarcinoma early detection and pulmonary nodule classification. Adv Sci (Weinh). 9(34):e2203786. doi:10.1002/advs.202203786.
   PubMedGoogle Scholar
• Wei Z, Lyu B, Hou D, Liu X. 2021. Mir-5100 mediates proliferation, migration and invasion of oral squamous cell carcinoma cells via targeting SCAI. J Invest Surg. 34(8):834–841. doi:10.1080/08941939.2019.1701754.
   PubMed Web of Science ®Google Scholar
• Wu FZ, Huang YL, Wu YJ, Tang EK, Wu MT, Chen CS, Lin YP. 2020. Prognostic effect of implementation of the mass low-dose computed tomography lung cancer screening program: a hospital-based cohort study. Eur J Cancer Prev. 29(5):445–451. doi:10.1097/CEJ.0000000000000569.
   PubMed Web of Science ®Google Scholar
• Yang L, Lin Z, Wang Y, Gao S, Li Q, Li C, Xu W, Chen J, Liu T, Song Z, et al. 2018. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6. Mol Carcinog. 57(3):419–428. doi:10.1002/mc.22765.
   PubMed Web of Science ®Google Scholar
• Yang L, Qin Y, Jian C. 2021. Screening for core genes related to pathogenesis of Alzheimer’s disease. Front Cell Dev Biol. 9:668738. doi:10.3389/fcell.2021.668738.
   PubMed Web of Science ®Google Scholar
• Yang F, Wang X, Ma H, Li J. 2021. Transformers-sklearn: a toolkit for medical language understanding with transformer-based models. BMC Med Inform Decis Mak. 21(Suppl 2):90. doi:10.1186/s12911-021-01459-0.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhang R, Zheng W, Liu S, Zhou F. 2017. RIFS: a randomly restarted incremental feature selection algorithm. Sci Rep. 7(1):13013. doi:10.1038/s41598-017-13259-6.
   PubMedGoogle Scholar
• Yuan Q, Chen K, Yu Y, Le NQK, Chua MCH. 2023. Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding. Briefings in Bioinformatics. 24(1):bbac630. doi:10.1093/bib/bbac630.
   Web of Science ®Google Scholar
• Zekri AR, Youssef AS, Lotfy MM, Gabr R, Ahmed OS, Nassar A, Hussein N, Omran D, Medhat E, Eid S, et al. 2016. Circulating serum miRNAs as diagnostic markers for colorectal cancer. PLoS One. 11(5):e0154130. doi:10.1371/journal.pone.0154130.
   PubMed Web of Science ®Google Scholar
• Zhang Z. 2016. Introduction to machine learning: k-nearest neighbors. Ann Transl Med. 4(11):218. doi:10.21037/atm.2016.03.37.
   PubMed Web of Science ®Google Scholar
• Zhao S, Xiong W, Xu K. 2020. MiR-663a, regulated by lncRNA GAS5, contributes to osteosarcoma development through targeting MYL9. Hum Exp Toxicol. 39(12):1607–1618. doi:10.1177/0960327120937330.
   PubMed Web of Science ®Google Scholar